Global Drugs for Malaria Market by Key Players, Regions, Type and Application, Forecast to 2023
Global Drugs for Malaria Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023 Provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments.
(EMAILWIRE.COM, September 27, 2018 ) Global Drugs for Malaria Market 2018-2023
Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease.
Anti-malarial Drugs are available only with a physician's prescription. They come in tablet, capsule, and injectable forms. Among the commonly used anti-malarial drugs are chloroquine, mefloquine, primaquine, pyrimethamine, and quinine.
Scope of the Global Drugs for Malaria Market Report
This report focuses on the Drugs for Malaria in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Request a Sample of this Report @ http://www.orbisresearch.com/contacts/request-sample/2310061
The classification of drugs for malaria includes aryl aminoalcohol compounds, antifolate compounds and artemisinin compounds. The proportion of aryl aminoalcohol compounds drugs for malaria in 2016 is about 16.8%, the proportion of antifolate compounds in 2016 is about 55.4% and the proportion of artemisinin compounds in 2016 is about 27.8%.
Drugs for malaria are application in Preventioning malaria, curing malaria and other areas. The most of drugs for malaria is used in Preventioning malaria; the market share in 2016 is about 56.1%. And 35.1% of drugs for malaria are used in curing malaria.
Market competition is intense. The major manufacturers are Cipla, Guilin Pharmaceutical, IPCA Laboratories, GlaxoSmithKline, Mylan Labs, Roche, Novartis, Sanofi Aventis and Ajanta Pharma in the United States.
The worldwide market for Drugs for Malaria is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Browse the Full Report @ http://www.orbisresearch.com/reports/index/global-drugs-for-malaria-market-2018-by-manufacturers-regions-type-and-application-forecast-to-2023
This report covers Analysis of Global Drugs for Malaria Market Segment by Manufacturers
Cipla
Guilin Pharmaceutical
IPCA Laboratories
GlaxoSmithKline
Mylan Labs
Roche
Novartis
Sanofi Aventis
Ajanta Pharma
Global Drugs for Malaria Market Segment by regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Make an enquiry before buying this report @ http://www.orbisresearch.com/contacts/enquiry-before-buying/2310061
Global Drugs for Malaria Market Segment by Type
Aryl Aminoalcohol Compounds
Antifolate Compounds
Artemisinin Compounds
Global Drugs for Malaria Market Segment by Applications, can be divided into
Prevention
Treatment
Other
Some of the Points cover in Global Drugs for Malaria Market Research Report is:
Chapter 1: Describe Drugs for Malaria Industry
Introduction,
Product Scope,
Market Overview,
Market Opportunities,
Market Risk,
Market Driving Force
Chapter 2: To analyze the top manufacturers of Drugs for Malaria Industry in 2016 and 2017
Sales
Revenue and price
Chapter 3: Competitive analysis among the top manufacturers in 2016 and 2017
Sales
Revenue and market share
Chapter 4: Global Drugs for Malaria Market by regions from 2013 to 2018
Sales
Revenue and market share
Chapter 5, 6, 7 and 8: Global Drugs for Malaria Market by key countries in these regions
Sales
Revenue and market share
Chapter 9 and 10: Global Drugs for Malaria Market by type and application from 2013 to 2018
Sales
Revenue and market share
Growth rate
Chapter 11:Drugs for Malaria Industry Market forecast from 2018 to 2023
Regions
Type and application with sales and revenue
Chapter 12 and 13:Drugs for Malaria Industry
Sales channel
Distributors
Traders and dealers
Appendix
Data source
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Contact Us:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas - 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +912064101019
Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease.
Anti-malarial Drugs are available only with a physician's prescription. They come in tablet, capsule, and injectable forms. Among the commonly used anti-malarial drugs are chloroquine, mefloquine, primaquine, pyrimethamine, and quinine.
Scope of the Global Drugs for Malaria Market Report
This report focuses on the Drugs for Malaria in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Request a Sample of this Report @ http://www.orbisresearch.com/contacts/request-sample/2310061
The classification of drugs for malaria includes aryl aminoalcohol compounds, antifolate compounds and artemisinin compounds. The proportion of aryl aminoalcohol compounds drugs for malaria in 2016 is about 16.8%, the proportion of antifolate compounds in 2016 is about 55.4% and the proportion of artemisinin compounds in 2016 is about 27.8%.
Drugs for malaria are application in Preventioning malaria, curing malaria and other areas. The most of drugs for malaria is used in Preventioning malaria; the market share in 2016 is about 56.1%. And 35.1% of drugs for malaria are used in curing malaria.
Market competition is intense. The major manufacturers are Cipla, Guilin Pharmaceutical, IPCA Laboratories, GlaxoSmithKline, Mylan Labs, Roche, Novartis, Sanofi Aventis and Ajanta Pharma in the United States.
The worldwide market for Drugs for Malaria is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Browse the Full Report @ http://www.orbisresearch.com/reports/index/global-drugs-for-malaria-market-2018-by-manufacturers-regions-type-and-application-forecast-to-2023
This report covers Analysis of Global Drugs for Malaria Market Segment by Manufacturers
Cipla
Guilin Pharmaceutical
IPCA Laboratories
GlaxoSmithKline
Mylan Labs
Roche
Novartis
Sanofi Aventis
Ajanta Pharma
Global Drugs for Malaria Market Segment by regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Make an enquiry before buying this report @ http://www.orbisresearch.com/contacts/enquiry-before-buying/2310061
Global Drugs for Malaria Market Segment by Type
Aryl Aminoalcohol Compounds
Antifolate Compounds
Artemisinin Compounds
Global Drugs for Malaria Market Segment by Applications, can be divided into
Prevention
Treatment
Other
Some of the Points cover in Global Drugs for Malaria Market Research Report is:
Chapter 1: Describe Drugs for Malaria Industry
Introduction,
Product Scope,
Market Overview,
Market Opportunities,
Market Risk,
Market Driving Force
Chapter 2: To analyze the top manufacturers of Drugs for Malaria Industry in 2016 and 2017
Sales
Revenue and price
Chapter 3: Competitive analysis among the top manufacturers in 2016 and 2017
Sales
Revenue and market share
Chapter 4: Global Drugs for Malaria Market by regions from 2013 to 2018
Sales
Revenue and market share
Chapter 5, 6, 7 and 8: Global Drugs for Malaria Market by key countries in these regions
Sales
Revenue and market share
Chapter 9 and 10: Global Drugs for Malaria Market by type and application from 2013 to 2018
Sales
Revenue and market share
Growth rate
Chapter 11:Drugs for Malaria Industry Market forecast from 2018 to 2023
Regions
Type and application with sales and revenue
Chapter 12 and 13:Drugs for Malaria Industry
Sales channel
Distributors
Traders and dealers
Appendix
Data source
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Contact Us:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas - 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +912064101019
Contact Information:
Orbis Research
Hector Costello
Tel: +1 (214) 884-6817
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Orbis Research
Hector Costello
Tel: +1 (214) 884-6817
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results